Resazurin Viability Assay
Resazurin Viability Assay - Related Videos
06:08
A Charcoal Agar Resazurin Assay to Evaluate Test Compound Activity Against Mycobacteria
0 Views •
2025
This video showcases the Charcoal Agar Resazurin Assay (CARA) for evaluating the activity of antimicrobial compounds against Mycobacterium tuberculosis. CARA aids in assessing the efficacy of these compounds by gauging their impact on bacterial growth and distinguishing between bactericidal and bacteriostatic effects.
10:00
Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
0 Views •
Cited by 20 •
2016
Most bacterial infections produce a biofilm. By virtue of their environment, biofilm associated bacteria are often phenotypically drug resistant. Novel antibacterial molecules that kill bacteria in biofilms are thus a high priority. We establish an assay to quickly screen for antimicrobial compounds that are effective at eradicating biofilms.
12:03
Viability Assays for Cells in Culture
0 Views •
Cited by 39 •
2014
Therapeutic compounds are often first examined in vitro with viability assays. Blind cell counts by a human observer can be highly sensitive to small changes in cell number but do not assess function. Computerized viability assays, as described here, can assess both structure and function in an objective manner.
03:20
XTT Assay: A Colorimetric Assay to Assess Cell Viability and Mitochondrial Activity
0 Views •
2023
This article describes the protocol for XTT assay which is a colorimetric assay to assess cell viability and mitochondrial activity.
07:28
Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant
0 Views •
Cited by 6 •
2016
Here we present a fluorophore based imaging technique to detect cell viability on a non-transparent titanium scaffold as well as to detect glimpses of the scaffold impurities. This protocol troubleshoots the drawback of imaging cell-cell or cell-metal interactions on non-transparent scaffolds.
FAQs
Intracellular metabolic activity reduces blue, nonfluorescent resazurin to pink, fluorescent resorufin. This chemical conversion links cellular metabolism to an assay signal: greater production of resorufin indicates greater metabolic activity in the measured cell population. Researchers can then quantify the resulting change through fluorescence or absorbance to compare cellular viability across experimental conditions.
The signal primarily indicates the presence and metabolic activity of living cells rather than providing a direct count of individual cells. A stronger fluorescence or absorbance response is associated with more detectable metabolic activity in the population. Consequently, researchers should interpret results as an estimate of cellular viability or activity, especially when comparing treated and untreated conditions.
Resazurin reduction produces resorufin, which has a fluorescent signal and also changes the assay's color. Fluorescence measurement detects the emitted signal, whereas absorbance measurement evaluates the optical change associated with the conversion. Both approaches provide quantitative readouts for comparing conditions, allowing the assay to fit different experimental measurement strategies without requiring direct cell counting.
Researchers measure the resazurin-derived signal from cell populations exposed to different experimental conditions and compare the resulting fluorescence or absorbance values. Because the readout reflects metabolic activity, differences between conditions can indicate changes in cellular survival or health. This design supports evaluation of how an infectious agent or candidate treatment influences the measured population.
In immunology research, the assay helps estimate whether immune-cell populations remain viable and metabolically active under defined experimental conditions. Comparing signal levels between conditions can reveal changes in cellular health or survival without requiring researchers to count each cell individually. This makes the method useful when studying how experimental treatments or infectious agents affect immune-cell populations.
The method can be used to assess microbial growth as well as the effects of infectious agents on cells. It also supports testing candidate treatments by comparing metabolic readouts across experimental conditions. Depending on the population examined, the resulting signal can therefore inform studies of microbial viability, host-cell survival, or treatment-associated changes in cellular activity.